Early development of infants with neurofibromatosis type 1: a case series

Anna May Kolesnik1, Emily Jane Harrison Jones1, Shruti Garg2

  • 1Centre for Brain and Cognitive Development and Department of Psychology, Birkbeck, University of London, Malet Street, London, WC1E 7HX UK.

Molecular Autism
|December 6, 2017
PubMed

Insights

Infants with neurofibromatosis type 1 (NF1) show early motor and communication delays, similar to those seen in infants later diagnosed with autism spectrum disorder (ASD). These findings highlight motor function as crucial for understanding ASD development.

Area of Science:

  • Developmental neuroscience
  • Genetics
  • Autism spectrum disorder research

Background:

  • Autism spectrum disorder (ASD) studies in at-risk infants offer insights but have heterogeneous samples.
  • Studying infants with monogenic syndromes, like neurofibromatosis type 1 (NF1), provides a clearer etiological pathway to understand ASD development.
  • NF1 is a monogenic disorder with a high prevalence of ASD or ASD symptomatology.

Observation:

  • A prospective study examined ten 10-month-old infants with NF1.
  • Data were compared to a large cohort of infants at familial risk for ASD (categorized by 3-year outcome: ASD, atypical development, typical development) and low-risk controls.
  • Assessments at 10 months included cognitive, adaptive, sensory, social, and temperamental domains via parent report and observation.

Findings:

  • Infants with NF1 exhibited significant motor impairments compared to low-risk controls.
  • This motor impairment pattern mirrored that of infants with familial risk for ASD (HR-ASD) who later developed ASD.
  • Both NF1 infants and the HR-ASD group demonstrated communication delays relative to low-risk controls.

Implications:

  • Early developmental difficulties in motor and communication domains are evident in 10-month-old infants with NF1.
  • Social skills were not notably impaired at this age in NF1 infants, similar to HR-ASD infants.
  • Findings suggest motor functioning is a key area for informing animal models of ASD and has clinical implications for early surveillance and intervention in NF1.
Abstract